Skip to main content

Table 2 The comparison of pooled performance measures in subgroups

From: Machine learning for prediction of asthma exacerbations among asthmatic patients: a systematic review and meta-analysis

 

AUROC

sensitivity

specificity

PLR

NLR

DOR

Machine learning(n)

 LR (8)

0.77 (0.73–0.81)

0.54 (0.37–0.70)

0.82 (0.72–0.89)

3.06 (2.19–4.28)

0.56 (0.41–0.76)

5.47 (3.35–8.95)

 Boosting (7)

0.84 (0.81–0.87)

0.68 (0.57–0.78)

0.85 (0.77–0.90)

4.44 (3.15–6.27)

0.37 (0.28–0.50)

11.86 (7.80–18.01)

 RF (6)

0.75 (0.71–0.78)

0.67 (0.59–0.73)

0.74 (0.65–0.81)

2.54 (1.82–3.54)

0.45 (0.36–0.57)

5.59 (3.29–9.49)

Sample size (n)

  < 10000 (7)

0.68 (0.64–0.72)

0.51 (0.36–0.65)

0.77 (0.63–0.87)

2.24 (1.61–3.11)

0.64 (0.53–0.77)

3.52 (2.44–5.08)

  > 10000 (16)

0.82 (0.78–0.85)

0.64 (0.56–0.72)

0.83 (0.78–0.87)

3.71 (3.00–4.58)

0.43 (0.35–0.53)

8.62 (6.25–11.89)

Age group(n)

 Children (4)

0.72 (0.67–0.75)

0.59 (0.40–0.76)

0.75 (0.55–0.88)

2.33 (1.54–3.51)

0.55 (0.41–0.74)

4.23 (2.72–6.57)

 Children_adults(6)

0.88 (0.84–0.90)

0.53 (0.37–0.68)

0.89 (0.86–0.92)

5.02 (4.05–6.22)

0.53 (0.38–0.73)

9.49 (5.83–15.44)

 Adults (13)

0.79 (0.75–0.82)

0.65 (0.55–0.74)

0.78 (0.72–0.83)

2.95 (2.32–3.75)

0.45 (0.35–0.57)

6.56 (4.37–9.86)

Outcome(n)

 ED/HP (15)

0.81 (0.77–0.84)

0.60 (0.49–0.70)

0.84 (0.78–0.88)

3.65 (2.86–4.65)

0.48 (0.38–0.61)

7.58 (5.35–10.74)

 AE (8)

0.78 (0.74–0.81)

0.64 (0.52–0.74)

0.77 (0.70–0.84)

2.82 (2.06–3.86)

0.47 (0.35–0.63)

6.01 (3.47–10.41)